Stage III Prostate Cancer AJCC v7 Active Not Recruiting Phase 2 Trials for Bicalutamide (DB01128)

IndicationStatusPhase
DBCOND0093329 (Stage III Prostate Cancer AJCC v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01251861Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerTreatment